(Research on the evolution prediction and individualized decision-making method of neoadjuvant therapy for lung cancer based on longitudinal causal inference and dynamic treatment strategies) Procurement review results announcement

Release time:2026/6/29

(Research on the evolution prediction and individualized decision-making method of neoadjuvant therapy for lung cancer based on longitudinal causal inference and dynamic processing strategies) The inquiry and procurement work has now ended, and the results are as follows:

1. Project name: Research on the evolution prediction and individualized decision-making method of neoadjuvant treatment for lung cancer based on longitudinal causal inference and dynamic treatment strategies

2. Project number: YY-FW-2026-D001

3. Review date: June 26, 2026

4. Announcement date: June 29, 2026 - June 30, 2026

5. Evaluation results:

A total of 3 suppliers participated in the quotation of this project. The inquiry team recommended the first-ranked quotation supplier as the pre-transaction supplier. The specific information is as follows:

Project name

supplier

price (Yuan)

candidate Ranking

Study on the evolution prediction and individualized decision-making method of neoadjuvant therapy for lung cancer based on longitudinal causal inference and dynamic treatment strategies

Chongqing Normal University

192,000

first place

Other candidates: Huajing Serui (Chongqing) Technology Co., Ltd. (second candidate for transaction).

6. List of inquiry groups: Chen Qian, Tan Weihunana.

7. Questioning Channels

If the relevant supplier has objections to the results, please submit a letter of challenge in writing as required during this publicity period. Overdue applications will not be accepted.

8. Contact information:

Contact person: Teacher Hu  

Contact number: 19823416007

Supervision hotline: 023 6805 9919

I would like to express my deep gratitude to the suppliers who actively participated in this procurement activity and hope to continue our cooperation in the future.